Tennessee moves to prevent Christa Pike's attorneys from examining drug used in failed execution

Key Points:

• Tennessee is seeking to block Christa Pike's attorneys from accessing leftover pentobarbital used in her failed execution, citing state laws that protect the identity of lethal injection drug suppliers to ensure continued access and supplier safety.
• Pike survived two doses of pentobarbital in September, with her attorneys arguing the drug likely did not enter her bloodstream properly, causing severe burns and blistering; the state contends it is complying with evidence preservation orders but opposes inspection of the drug vials.
• The Tennessee Department of Correction fears losing its lethal injection drug supplier if the supplier's identity is revealed, noting a previous supplier ceased communication after exposure, which could jeopardize future executions.
• Pike's legal team argues that access to the drug's labeling and storage information is crucial to understanding what went wrong during the botched execution, including potential issues with mixing, handling, or expiration.
• The failed execution has prompted scrutiny of Tennessee's lethal injection protocols, with calls from the governor-elect to explore alternative execution methods; Pike remains on death row and continues to suffer significant physical and psychological pain.